Charles L. Bisgaier

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

Michael Aviram, Mira Rosenblat, Scott S. Billecke et al. · Free Radical Biology and Medicine · 1999 · 600 citations

Life Sciences, Biochemistry, Redox Biochemistry +7

Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease

Kenichi Horinouchi, Shai Erlich, Daniel P. Perl et al. · Nature Genetics · 1995 · 477 citations

Life Sciences, Biochemistry, Pathology +15

Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities

Michael Aviram, Scott S. Billecke, Robert C. Sorenson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 454 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

High-Dose Recombinant Apolipoprotein A-I _Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice

Prediman K. Shah, Juliana Yano, Odette S. Reyes et al. · Circulation · 2001 · 378 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic<i>N</i>-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids

Robert C. Sorenson, Charles L. Bisgaier, Cary Hsu et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 326 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14